Patents by Inventor Sarah Garrett-Thomson

Sarah Garrett-Thomson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tumor necrosis factor 1B (TNF-1B) mutants and methods of use thereof to screen for candidate therapeutic compounds
    Patent number: 10717776
    Abstract: Disclosed are tumor necrosis factor receptor 1B (TNFR-1B) signaling targets and TNFR-1B mutants and their uses for treatment of diseases and disorders.
    Type: Grant
    Filed: April 5, 2018
    Date of Patent: July 21, 2020
    Assignee: Albert Einstein College of Medicine
    Inventors: Steven C. Almo, Sarah Garrett-Thomson, Ron Seidel
  • THERAPEUTIC TNFR-1B TARGETS AND USES THEREOF
    Publication number: 20180273604
    Abstract: Disclosed are tumor necrosis factor receptor 1B (TNFR-1B) signaling targets and TNFR-1B mutants and their uses for treatment of diseases and disorders.
    Type: Application
    Filed: April 5, 2018
    Publication date: September 27, 2018
    Applicant: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
    Inventors: Steven C. Almo, Sarah Garrett-Thomson, Ron Seidel